Free Shipping on orders over £75Tracked UK-wide delivery, 1-5 business daysProduct-specific purity and batch detailsPlain, discreet packaging on every orderPublished third-party reports where availableSecure Checkout, Card payments acceptedFree Shipping on orders over £75Tracked UK-wide delivery, 1-5 business daysProduct-specific purity and batch detailsPlain, discreet packaging on every orderPublished third-party reports where availableSecure Checkout, Card payments accepted
GHK-Cu (50mg)

Skin & Anti-Ageing

GHK-Cu 50mg

SKU: PCUK-GHKCU50

GHK-Cu 50mg is a lyophilised copper-peptide research vial. This laboratory format is distinct from a formulated copper-peptide skincare serum or cream.

Laboratory research material only. Supplied solely for non-clinical in-vitro work. Not for use in or on humans or animals. Do not ingest, inject, inhale, apply or otherwise administer.
In Stock
Same day dispatch cutoff19:18:29
£23.99GBP

£23.03 by bank transfer (4% off) · £22.07 by crypto (8% off), applied at checkout

CoA purity: 99.843%

✓Free standard delivery on orders of £75 or more

✓Tracked UK delivery, Standard £4.99 / Express £9.99

✓In-stock orders: same-day dispatch before 2pm UK, Monday–Friday excluding bank holidays

✓View COA, Batch 100238

✓Product and batch guide, GHK-Cu in the UK

Delivery thresholds use the goods subtotal before discounts. Optional signed delivery costs extra. Delivery terms · Returns policy

Description

This GHK-Cu listing supplies one lyophilised vial labelled 50mg. GHK CU and GHKCU are punctuation variants used for the same GHK-Cu copper-complex name. Search phrases such as copper peptide can also describe other compounds or finished cosmetic products, so the full identity and supplied form matter.

The product is a dry laboratory research material, not a skincare serum, cream or topical preparation. The 50mg vial label is an amount of material; it is not a cosmetic percentage or a concentration in a finished formulation.

Compare this listing using its GHK-Cu identity, labelled mass, physical form and available analytical documentation. Do not infer a product's suitability or performance from the term copper peptide alone.

A report is currently linked for batch 100238. Open the published report below to check its sample identity, reference, methods and results. A report describes the tested sample and does not establish sterility, suitability for personal use or results from tests it does not contain.

This is a laboratory research material for non-clinical in-vitro work. Do not ingest, inject, inhale, apply or otherwise administer it to a human or animal. Laboratory handling must follow a validated institutional SOP and risk assessment.

Product details

  • Catalogue identity: GHK-Cu (50mg)
  • Labelled quantity: 50mg / vial
  • Supplied form: Lyophilised powder
  • Published report linked for batch 100238
  • Supplied solely for non-clinical in-vitro laboratory research. Not for use in or on humans or animals.
Product Specifications
CompoundGHK-Cu (50mg)
CAS Number89030-95-5
CategorySkin & Cellular Research
SequenceGly-His-Lys (copper complex)
Purity99.843% (CoA reported, HPLC)
FormLyophilised powder
AppearanceLight blue lyophilised powder (copper complex coloration)
Quantity50mg / vial
Storage (Lyophilised)−20°C for long-term storage
Storage ConditionsKeep the material sealed and follow the storage conditions on its label and available batch documentation. Prepared-sample conditions and stability depend on a validated laboratory SOP; this page does not specify a universal shelf life after preparation.
Batch100238
SKUPCUK-GHKCU50

⚠ GHK-Cu (50mg) is supplied solely for lawful non-clinical in-vitro laboratory research. It is not licensed by the MHRA for medicinal use and must not be used in or on a human or animal. No diagnosis, treatment, prevention, cosmetic or in-vivo use is offered. You must be 18 or older to purchase.

Frequently Bought Together

Product questions

What is supplied when I buy GHK-Cu 50mg?

One lyophilised laboratory research vial labelled 50mg of GHK-Cu. It is not supplied as a skincare serum, cream or other finished cosmetic formulation.

Are GHK CU and GHKCU the same as GHK-Cu?

GHK CU, GHKCU and GHK-Cu are written forms of the same compound name. The broader phrase copper peptide can describe other compounds or finished products. Confirm GHK-Cu, the 50mg quantity and the lyophilised research format rather than treating every copper-peptide listing as equivalent.

Does 50mg mean a 50mg/mL copper-peptide solution?

No. The 50mg label is the amount supplied in a dry vial. It does not specify a solution volume, mg/mL concentration or a percentage in a cosmetic product.

Is this the same format as a GHK-Cu skincare serum?

No. A finished serum has its own formulation and intended use. This product is a lyophilised material for non-clinical in-vitro laboratory work and must not be applied to skin or used in or on humans or animals.

What is the current price and availability of GHK-Cu?

GHK-Cu (50mg) is currently in stock. The current listed price is £23.99 per vial. Delivery charges and any applicable order discounts are calculated separately at checkout; the product price is not a delivered-order total.

Is a current batch certificate of analysis available?

A report is currently linked for batch 100238. Open the published report below to check its sample identity, reference, methods and results. A report describes the tested sample and does not establish sterility, suitability for personal use or results from tests it does not contain.

How should GHK-Cu be stored?

Keep the material sealed and follow the storage conditions on its label and available batch documentation. Prepared-sample conditions and stability depend on a validated laboratory SOP; this page does not specify a universal shelf life after preparation.

What is the permitted scope of use?

Supplied solely for non-clinical in-vitro laboratory research. Not for use in or on humans or animals. We do not provide dosing, administration, cosmetic-use or in-vivo protocols. Laboratory handling must follow a validated institutional SOP and risk assessment.

Research and documentation